Status:

UNKNOWN

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

Lead Sponsor:

Affiliated Hospital of Guangdong Medical University

Conditions:

Hemophilia B Without Inhibitor

Eligibility:

MALE

12+ years

Phase:

EARLY_PHASE1

Brief Summary

This is an open- label, non- randomized, uncontrolled, dose-escalation pilot study to evaluate the safety and efficacy of KL001 injection solution in hemophilia B subjects with ≤2 IU/dl residual FIX l...

Detailed Description

This is an open- label, non- randomized, uncontrolled, dose-escalation pilot study to evaluate the safety and efficacy of KL001 injection solution in hemophilia B subjects with ≤2 IU/dl residual FIX l...

Eligibility Criteria

Inclusion

  • Male ≥12 years of age.
  • Moderate/severe or severe hemophilia B (baseline FIX activity ≤2% of normal or documented history of FIX activity ≤2%).
  • At least 3 bleeding episodes per year that require on-demand treatment with FIX or are treated with a prophylactic regimen of FIX.
  • At least 100 days exposure history to recombinant or plasma-derived FIX protein products.
  • No neutralizing antibodies to exogenous FIX protein products.
  • Willing and able to comply with study procedures and requirements.

Exclusion

  • Suffering from chronic inflammatory muscle disease.
  • Positive in Hepatitis B or Hepatitis C.
  • Infection with HIV-1 or HIV-2 and CD4+T cell count ≤ 200/ μ L.
  • History of thrombosis or susceptibility to thrombosis.
  • Current or previous participation in another gene therapy study.
  • Has any other significant medical condition that the investigator feels would be a risk to the subject or would impede the study.

Key Trial Info

Start Date :

December 20 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 30 2025

Estimated Enrollment :

9 Patients enrolled

Trial Details

Trial ID

NCT06125756

Start Date

December 20 2023

End Date

October 30 2025

Last Update

November 9 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001 | DecenTrialz